Healthcare
Tuesday, January 3, 2017
BRIEF-Newron Pharmaceuticals says encouraging preliminary results of Phase IIA study with Evenamide
* Newron Pharmaceuticals SPA - Newron announces encouraging
preliminary results of its Phase IIA study with Evenamide in
patients with schizophrenia
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment